인쇄하기
취소

What are chances for domestic biosimilars to succeed in global market?

Published: 2016-06-01 14:37:00
Updated: 2016-06-01 14:37:00

Foreign expansion of Korean competitive biomedicines is going to be active.

The leading biosimilar companies are Celltrion and Samsung Bioepis. The two companies gave notices of the launch of the autoimmune treatment, ‘Remicade,’ to the European and U.S. markets, the largest biosimilar markets.

Recently, in addition, SK Chemicals acquired the final commercialization approval of Afstyla, a hem...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.